Folgen
Wojciech Krzyzanski
Wojciech Krzyzanski
Associate Professor of Pharmaceutical Sciences, University at Buffalo
Bestätigte E-Mail-Adresse bei buffalo.edu
Titel
Zitiert von
Zitiert von
Jahr
Quasi-equilibrium pharmacokinetic model for drugs exhibiting target-mediated drug disposition
DE Mager, W Krzyzanski
Pharmaceutical research 22, 1589-1596, 2005
2362005
Mathematical modeling of circadian cortisol concentrations using indirect response models: comparison of several methods
A Chakraborty, W Krzyzanski, WJ Jusko
Journal of pharmacokinetics and biopharmaceutics 27, 23-43, 1999
1231999
Pharmacokinetic and pharmacodynamic modeling of recombinant human erythropoietin after multiple subcutaneous doses in healthy subjects
W Krzyzanski, WJ Jusko, MC Wacholtz, N Minton, WK Cheung
European journal of pharmaceutical sciences 26 (3-4), 295-306, 2005
1092005
Basic pharmacodynamic models for agents that alter production of natural cells
W Krzyzanski, R Ramakrishnan, WJ Jusko
Journal of pharmacokinetics and biopharmaceutics 27, 467-489, 1999
1051999
Pharmacokinetics of anti-hepcidin monoclonal antibody Ab 12B9m and hepcidin in cynomolgus monkeys
JJ Xiao, W Krzyzanski, YM Wang, H Li, MJ Rose, M Ma, Y Wu, B Hinkle, ...
The AAPS journal 12, 646-657, 2010
992010
Selection between Michaelis–Menten and target-mediated drug disposition pharmacokinetic models
X Yan, DE Mager, W Krzyzanski
Journal of pharmacokinetics and pharmacodynamics 37, 25-47, 2010
962010
Target-mediated pharmacokinetic and pharmacodynamic model of recombinant human erythropoietin (rHuEPO)
S Woo, W Krzyzanski, WJ Jusko
Journal of pharmacokinetics and pharmacodynamics 34, 849-868, 2007
782007
Pharmacokinetic and pharmacodynamic modeling of recombinant human erythropoietin after intravenous and subcutaneous administration in rats
S Woo, W Krzyzanski, WJ Jusko
Journal of Pharmacology and Experimental Therapeutics 319 (3), 1297-1306, 2006
782006
Pharmacodynamics-mediated drug disposition (PDMDD) and precursor pool lifespan model for single dose of romiplostim in healthy subjects
YMC Wang, W Krzyzanski, S Doshi, JJ Xiao, JJ Pérez-Ruixo, AT Chow
The AAPS journal 12, 729-740, 2010
742010
Mathematical formalism for the properties of four basic models of indirect pharmacodynamic responses
W Krzyzanski, WJ Jusko
Journal of pharmacokinetics and biopharmaceutics 25, 107-123, 1997
731997
Pharmacodynamic model for chemotherapy-induced anemia in rats
S Woo, W Krzyzanski, WJ Jusko
Cancer chemotherapy and pharmacology 62, 123-133, 2008
632008
Population modeling of filgrastim PK‐PD in healthy adults following intravenous and subcutaneous administrations
W Krzyzanski, P Wiczling, P Lowe, E Pigeolet, M Fink, A Berghout, ...
The Journal of Clinical Pharmacology 50 (S9), 101S-112S, 2010
602010
Pharmacokinetic model of target-mediated disposition of thrombopoietin
F Jin, W Krzyzanski
AAPS PharmSci 6, 86-93, 2004
562004
Assessment of drug interactions relevant to pharmacodynamic indirect response models
J Earp, W Krzyzanski, A Chakraborty, MK Zamacona, WJ Jusko
Journal of pharmacokinetics and pharmacodynamics 31, 345-380, 2004
512004
Pharmacodynamic models for agents that alter production of natural cells with various distributions of lifespans
W Krzyzanski, S Woo, WJ Jusko
Journal of pharmacokinetics and pharmacodynamics 33, 125-166, 2006
502006
Integrated functions for four basic models of indirect pharmacodynamic response
W Krzyzanski, WJ Jusko
Journal of pharmaceutical sciences 87 (1), 67-72, 1998
501998
Pharmacodynamic analysis of recombinant human erythropoietin effect on reticulocyte production rate and age distribution in healthy subjects
JJ Pérez-Ruixo, W Krzyzanski, J Hing
Clinical pharmacokinetics 47, 399-415, 2008
492008
Quantitative prediction of human pharmacokinetics for mAbs exhibiting target-mediated disposition
AP Singh, W Krzyzanski, SW Martin, G Weber, A Betts, A Ahmad, ...
The AAPS journal 17, 389-399, 2015
482015
Population cell life span models for effects of drugs following indirect mechanisms of action
JJ Perez-Ruixo, HC Kimko, AT Chow, V Piotrovsky, W Krzyzanski, ...
Journal of pharmacokinetics and pharmacodynamics 32, 767-793, 2005
482005
Algorithm for application of Fourier analysis for biorhythmic baselines of pharmacodynamic indirect response models
W Krzyzanski, A Chakraborty, WJ Jusko
Chronobiology international 17 (1), 77-93, 2000
482000
Das System kann den Vorgang jetzt nicht ausführen. Versuchen Sie es später erneut.
Artikel 1–20